Skip to Main Content

Paper Details

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.
Front Oncol
7
2022
LAG3, LAG3 protein, PD-1, PD-L1, RCC, RCC tumors, VEGFR-, advanced renal cell carcinoma, anti-PD-, brain metastases, grade 4 tumors, leukocytes, metastases, metastatic melanoma, metastatic tumors, patients, primary tumor, primary tumors, relatlimab, renal cell carcinoma, tumor
Author NameAffiliation
Adebowale J AdeniranYale School of Medicine
Michael E HurwitzYale School of Medicine
David L RimmYale School of Medicine
Harriet M KlugerYale School of Medicine
Harriet M KlugerYale School of Medicine
  • 1 - 5

Datasets

Release 1.2